Our work is delivered through five Technical Working Groups, each focusing on a key area where coordinated action can help improve equitable access to, and the effective use of, diagnostics, particularly in low- and middle-income countries.
Each Technical Working Group is co-chaired by experts from across the global AMR community and develops practical outputs to support innovation, evidence generation, policy development, and implementation.
Our Technical Working Groups
Innovation and evidence generation
Co-chairs: Jesus Rodriguez Manzano and Betsy W. Trainor
This working group focuses on strengthening the evidence base for AMR diagnostics. Its work includes exploring ways to maximise the value of existing laboratory data, supporting the development of innovative diagnostic technologies, and advancing rapid pathogen identification, antimicrobial susceptibility testing, and point-of-care diagnostics.
Access and market shaping
Co-chairs: Tim Meehan and Mirfin Mpundu
This group is working to better understand the barriers that limit access to diagnostics and to identify opportunities to improve availability and uptake. Current activities include country-level surveys to map access challenges and explore approaches that could be adapted across different regions.
Economics and policy
Co-chairs: Jyoti Joshi and Nina Zhu
The Economics and Policy Working Group is building the evidence needed to demonstrate the value of diagnostics in addressing AMR. Current priorities include developing the economic case for diagnostics and creating practical frameworks and metrics to support policy and investment decisions.
Country readiness and capacity
Co-chairs: Sylvanus Tekwe and Raheelah Ahmad
This working group focuses on strengthening national capacity to adopt and sustain diagnostic solutions. Activities include assessing local manufacturing capabilities and identifying examples of good practice that can be shared and adapted across countries.
Regulation and quality governance
Co-chairs: Jean-Baptiste Ronat and Peter Howitt
This group aims to support countries in developing robust regulatory and quality assurance systems for diagnostics. Current priorities include producing practical guidance for local manufacturing and exploring opportunities for training and collaboration to strengthen regulatory capacity.